Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales.
Trotter, CL; EDMUNDS, WJ;
2002
BMJ, (2002).324 7341 10.1136/bmj.324.7341.809.
Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study.
Taylor, B; MILLER, E; Lingam, R; Andrews, N; Simmons, A; Stowe, J;
2002
BMJ (Clinical research ed), (2002).324 7334 10.1136/bmj.324.7334.393.
GAVI, the first steps: lessons for the Global Fund.
Brugha, R; Starling, M; WALT, G;
2002
Lancet, (2002).359 9304 10.1016/S0140-6736(02)07607-9.
The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales.
EDMUNDS, WJ; Brisson, M; Melegaro, A; Gay, NJ;
2002
Vaccine, (2002).20 9-10 10.1016/s0264-410x(01)00473-x.
Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E.
Hasan, UA; Harper, DR; WREN, BW; Morrow, WJ W;
2002
Vaccine, (2002).20 9-10 10.1016/s0264-410x(01)00475-3.
The cost-effectiveness of varicella vaccination in Canada.
Brisson, M; EDMUNDS, WJ;
2002
Vaccine, (2002).20 7-8 10.1016/s0264-410x(01)00437-6.
Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain.
Da Cunha, SS; RODRIGUES, LC; Barreto, ML; Dourado, I;
2002
Vaccine, (2002).20 7-8 10.1016/s0264-410x(01)00438-8.
Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania.
Acosta, CJ; Galindo, CM; SCHELLENBERG, D; Aponte, JJ; Kahigwa, E; Urassa, H; SCHELLENBERG, JR; Masanja, H; HAYES, R; Kitua, AY; Lwilla, F; Mshinda, H; Menendez, C; Tanner, M; Alonso, PL;
2002
Tropical medicine & international health : TM & IH, (2002).4 5 10.1046/j.1365-3156.1999.00406.x.
Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.
SCHELLENBERG, DM; Acosta, CJ; Galindo, CM; Kahigwa, E; Urassa, H; Masanja, H; Aponte, JJ; SCHELLENBERG, JR; Fraser-Hurt, N; Lwilla, F; Menendez, C; Mshinda, H; Tanner, M; Alonso, PL;
2002
Tropical medicine & international health : TM & IH, (2002).4 5 10.1046/j.1365-3156.1999.00424.x.
L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output.
Atkins, NS; CONWAY, DJ; Lindo, JF; Bailey, JW; BUNDY, DA;
2002
Parasite immunology, (2002).21 10 10.1046/j.1365-3024.1999.00248.x.